<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Studies in a variety of cell types have suggested that <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> chemotherapy drugs induce <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cell <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in part by inducing formation of reactive oxygen species (ROS) </plain></SENT>
<SENT sid="1" pm="."><plain>Using human B <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cells as the targets, we have found that <z:mpath ids='MPATH_3'>apoptosis</z:mpath> can be induced in the absence of any detectable <z:mp ids='MP_0003674'>oxidative stress</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain><z:mpath ids='MPATH_3'>Apoptosis</z:mpath> was induced with the chemotherapy drugs <z:chebi fb="0" ids="4911">VP-16</z:chebi> and <z:chebi fb="2" ids="27899">cisplatin</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>To determine whether oxidants are formed as part of the drug-induced apoptotic process, intracellular markers of <z:mp ids='MP_0003674'>oxidative stress</z:mp> were examined </plain></SENT>
<SENT sid="4" pm="."><plain>These included measurement of (1) protein <z:chebi fb="0" ids="23019">carbonyl groups</z:chebi> by Western blot immunoassay, (2) protein <z:chebi fb="0" ids="49033">methionine sulfoxide</z:chebi> residues by amino acid analysis, (3) protein sulfhydryl oxidation by Western blot immunoassay, (4) F2-isoprostanes by GC/MS, and (5) intracellular ROS production using the oxidant-sensitive dyes DCFDA and dihydrorhodamine 123 </plain></SENT>
<SENT sid="5" pm="."><plain><z:mpath ids='MPATH_3'>Apoptosis</z:mpath> was quantified using fluorescence microscopy to assess nuclear <z:mp ids='MP_0000002'>morphology</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>The results show that <z:chebi fb="0" ids="4911">VP-16</z:chebi> and <z:chebi fb="2" ids="27899">cisplatin</z:chebi> induce extensive <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in the absence of any detectable protein or <z:chebi fb="23" ids="18059">lipid</z:chebi> oxidation, measured in both the cytosolic and <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> compartments of the cell </plain></SENT>
<SENT sid="7" pm="."><plain>In contrast, <z:chebi fb="0" ids="30492">H2O2</z:chebi>, which kills the cells by nonapoptotic pathways, caused increases in both protein and <z:chebi fb="23" ids="18059">lipid</z:chebi> oxidation </plain></SENT>
<SENT sid="8" pm="."><plain>Three different <z:chebi fb="11" ids="22586">antioxidant</z:chebi> compounds (N-<z:chebi fb="9" ids="46887">acetyl</z:chebi> cysteine, Tempol, and MnTBAP) failed to inhibit <z:chebi fb="0" ids="4911">VP-16</z:chebi>-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, while inhibiting <z:chebi fb="0" ids="30492">H2O2</z:chebi>-induced cell <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>Only N-<z:chebi fb="9" ids="46887">acetyl</z:chebi> cysteine inhibited <z:chebi fb="2" ids="27899">cisplatin</z:chebi>-induced cell <z:hpo ids='HP_0011420'>death</z:hpo> and this is attributed to its known ability to react directly with and inactivate <z:chebi fb="2" ids="27899">cisplatin</z:chebi> before it enters the cell </plain></SENT>
<SENT sid="10" pm="."><plain>The results demonstrate that, at least in B <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cells, chemotherapy-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> occurs using a mechanism that does not involve oxidants </plain></SENT>
</text></document>